Molecular sonography with targeted microbubbles: Current investigations and potential applications

Ultrasound Quarterly

Volumn 26, Issue 2, 2010, Pages 75-82

  Hwang, Misun ^a   Lyshchik, Andrej ^a   Fleischer, Arthur C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Sonography; Targeted microbubbles

Indexed keywords

CANCER DIAGNOSIS; CARCINOGENESIS; CONTRAST ENHANCEMENT; DRUG DELIVERY SYSTEM; EARLY DIAGNOSIS; ECHOGRAPHY; GRAFT REJECTION; IMAGE ACQUISITION; IMAGE ANALYSIS; INFLAMMATION; ISCHEMIA; MICROBUBBLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPERFUSION INJURY; REVIEW; TREATMENT RESPONSE;

ANIMALS; COHORT STUDIES; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; FORECASTING; HUMANS; MICE; MICROBUBBLES; MOLECULAR IMAGING; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; REPERFUSION INJURY; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77952892389     PISSN: 08948771     EISSN: None     Source Type: Journal    
DOI: 10.1097/RUQ.0b013e3181df96de     Document Type: Review

References (63)

1. Fleischer AC, Lyshchik A, Jones HW Jr, et al. Contrast- enhancedtransvaginal sonography of benign versus malignant ovarian masses: preliminary findings. J Ultrasound Med. 2008;27:1011-1018.
2. Krix M, Kiessling F, Vosseler S, et al. Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography. Cancer Res. 2003;63:8264-8270.
3. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation. 1998;97:473-483.
4. Lyshchik A, Fleischer AC, Huamani J, et al. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography. J Ultrasound Med. 2007;26:1575-1586.
5. Needles A, Couture O, Foster ES. A method for differentiating targeted microbubbles in real time using subharmonic micro-ultrasound and interframe filtering. Ultrasound Med Biol. 2009;35:1564-1573.
6. Zhao S, Kruse DE, Ferrara KW, et al. Selective imaging of adherent targeted ultrasound contrast agents. Phys Med Biol. 2007;52:2055-2072.
7. Lassau N, Koscielny S, Opolon P, et al. Evaluation of contrast-enhanced color Doppler ultrasound for the quantification of angiogenesis in vivo. Invest Radiol. 2001;36:50-55.
8. Hallahan D, Geng L, Qu S, et al. Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels. Cancer Cell. 2003;3:63-74.
9. Niermann KJ, Fleischer AC, Huamani J, et al. Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography. J Ultrasound Med. 2007;26:749-756.
10. Lee DJ, Lyshchik A, Huamani J, et al. Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model. J Ultrasound Med. 2008;27:855-866.
11. Korpanty G, Carbon JG, Grayburn PA, et al. Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res. 2007;13:323-330.
12. Palmowski M, Huppert J, Ladewig G, et al. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther. 2008;7:101-109.
13. Willmann JK, Lutz AM, Paulmurugan R, et al. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo. Radiology. 2008;248:936-944.
14. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182-1186.
15. Turkbey B, Kobayashi H, Ogawa M, et al. Imaging of tumor angiogenesis: functional or targeted? AJR Am J Roentgenol. 2009;193:304-313.
16. Leong-Poi H, Christiansen J, Heppner P, et al. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation. 2005;111:3248-3254.
17. McLane MA, Marcinkiewicz C, Vijay-Kumar S, et al. Viper venom disintegrins and related molecules. Proc Soc Exp Biol Med. 1998;219:109-119.
18. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 1994;264:569-571.
19. Kim S, Harris M, Varner JA. Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A. J Biol Chem. 2000;275:33920-33928.
20. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.
21. Lindner JR, Song J, Christiansen J, et al. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Invest Radiol. 1968;3:356-366.
22. Villanueva FS, Jankowski RJ, Klibanov S, et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation. 1998;98:1-5.
23. Weller GE, Villanueva FS, Tom EM, et al. Targeted ultrasound contrast agents: in vitro assessment of endothelial dysfunction and multi-targeting to ICAM-1 and sialyl Lewisx. Biotechnol Bioeng. 2005;92:780-788.
24. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol. 1968;3:356-366.
25. Feinstein SB, Ten Cate FJ, Zwehl W, et al. Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents. J Am Coll Cardiol. 1984;3:14-20.
26. Hundley WG, Kizilbash AM, Afridi I, et al. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J Am Coll Cardiol. 1998;32:1426-1432.
27. Christiansen JP, Leong-Poi H, Klibanov AL, et al. Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography. Circulation. 2002;105:1764-1767.
28. Jing XX, Wang ZG, Ran HT, et al. Evaluation of renal ischemia-reperfusion injury in rabbits using microbubbles targeted to activated neutrophils. Clin Imaging. 2008;32:178-182.
29. Unger EC, McCreery TP, Sweitzer RH, et al. In vitro studies of a new thrombus-specific ultrasound contrast agent. Am J Cardiol. 1998;81:58G-61G.
30. Takeuchi M, Ogunyankin K, Pandian NG, et al. Enhanced visualization of intravascular and left atrial appendage thrombus with the use of a thrombus-targeting ultrasonographic contrast agent (MRX-408A1) : in vivo experimental echocardiographic studies. J Am Soc Echocardiogr. 1999;12:1015-1021.
31. Tsivgoulis G, Culp WC, Alexandrov AV. Ultrasound enhanced thrombolysis in acute arterial ischemia. Ultrasonics. 2008;48:303-311.
32. Molina CA, Ribo M, Rubiera M, et al. Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke. 2006;37:425-429.
33. Xie F, Tsutsui JM, Lof J, et al. Effectiveness of lipid microbubbles and ultrasound in declotting thrombosis. Ultrasound Med Biol. 2005;31:979-985.
34. Alonso A, Dempfle CE, Della Martina A, et al. In vivo clot lysis of human thrombus with intravenous abciximab immunobubbles and ultrasound. Thromb Res. 2009;124:70-74.
35. Adams HP Jr, Effron MB, Torner J, et al. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke. 2008;39:87-99.
36. Lindner JR. Molecular imaging of cardiovascular disease with contrast-enhanced ultrasonography. Nat Rev Cardiol. 2009;6:475-481.
37. Weller GE, Lu E, Csikari MM, et al. Ultrasound imaging of acute cardiac transplant rejection with microbubbles targeted to intercellular adhesion molecule-1. Circulation. 2003;108:218-224.
38. Kondo I, Ohmori K, Oshita A, et al. Leukocyte-targeted myocardial contrast echocardiography can assess the degree of acute allograft rejection in a rat cardiac transplantation model. Circulation. 2004;109:1056-1061.
39. Schneider M. Molecular imaging and ultrasound-assisted drug delivery. J Endourol. 2008;22:795-802.
40. Deckers R, Rome C, Moonen CT. The role of ultrasound and magnetic resonance in local drug delivery. J Magn Reson Imaging. 2008;27:400-409.
41. Mehier-Humbert S, Bettinger T, Yan F, et al. Ultrasound-mediated gene delivery: kinetics of plasmid internalization and gene expression. J Control Release. 2005;104:203-211.
42. Brayman AA, Coppage ML, Vaidya S, et al. Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1 MHz ultrasound. Ultrasound Med Biol. 1999;25:999-1008.
43. Vannan M, McCreery T, Li P, et al. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. J Am Soc Echocardiogr. 2002;15:214-218.
44. Haag P, Frauscher F, Gradl J, et al. Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. J Steroid Biochem Mol Biol. 2006;102:103-113.
45. Mehier-Humbert S, Yan F, Frinking P, et al. Ultrasound-mediated gene delivery: influence of contrast agent on transfection. Bioconjug Chem. 2007;18:652-662.
46. Mehier-Humbert S, Bettinger T, Yan F, et al. Influence of polymer adjuvants on the ultrasound-mediated transfection of cells in culture. Eur J Pharm Biopharm. 2009;72:567-573.
47. Stieger SM, Caskey CF, Adamson RH, et al. Enhancement of vascular permeability with low-frequency contrast-enhanced ultrasound in the chorioallantoic membrane model. Radiology. 2007;243:112-121.
48. Kooiman K, Emmer M, Foppen-Harteveld M, et al. Increasing the endothelial layer permeability through ultrasound-activated microbubbles. IEEE Trans Biomed Eng. 2010;57:29-32.
49. Xie F, Boska MD, Lof J, et al. Effects of transcranial ultrasound and intravenous microbubbles on blood brain barrier permeability in a large animal model. Ultrasound Med Biol. 2008;34:2028-2034.
50. Rychak JJ, Graba J, Cheung AM, et al. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Mol Imaging. 2007;6:289-296.
51. Willmann JK, Paulmurugan R, Chen K, et al. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology. 2008;246:508-518.
52. Willmann JK, Cheng Z, Davis C, et al. Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. Radiology. 2008;249:212-219.
53. Ellegala DB, Leong-Poi H, Carpenter JE, et al. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha (v) beta3. Circulation. 2003;108:336-341.
54. Weller GE, Wong MK, Modzelewski RA, et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res. 2005;65:533-539.
55. Leong-Poi H, Christiansen J, Klibanov AL, et al. Noninvasive assessment of angiogenesis by ultrasound and microbubbles targeted to alpha (v)-integrins. Circulation. 2003;107:455-460. (Pubitemid 36158049)
56. Hamilton AJ, Huang SL, Warnick D, et al. Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol. 2004;43:453-460.
57. Wu Y, Unger EC, McCreery TP, et al. Binding and lysing of blood clots using MRX-408. Invest Radiol. 1998;33:880-885.
58. Schumann PA, Christiansen JP, Quigley RM, et al. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol. 2002;37:587-593.
59. Andonian S, Coulthard T, Smith AD, et al. Real-time quantitation of renal ischemia using targeted microbubbles: in-vivo measurement of P-selectin expression. J Endourol. 2009;23:373-378.
60. Bachmann C, Klibanov AL, Olson TS, et al. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease. Gastroenterology. 2006;130:8-16.
61. Hauff P, Reinhardt M, Briel A, et al. Molecular targeting of lymph nodes with L-selectin ligand-specific US contrast agent: a feasibility study in mice and dogs. Radiology. 2004;231:667-673.
62. Linker RA, Reinhardt M, Bendszus M, et al. In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE). J Autoimmun. 2005;25:199-205.
63. Loveless ME, Li X, Huamani J, et al. A method for assessing the microvasculature in a murine tumor model using contrast-enhanced ultrasonography. J Ultrasound Med. 2008;27:1699-1709.